Anna Porębska

Title: Anna Porębska: Innovator in Monoclonal Antibodies

Introduction

Anna Porębska is a notable inventor based in Warsaw, Poland. She has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. Her work focuses on addressing the challenges posed by H5-serotype influenza viruses, which are critical in both human and animal health.

Latest Patents

Anna Porębska holds a patent for "Monoclonal antibodies against hemagglutinin of H5-serotype influenza viruses and their uses, hybridomas producing said antibodies, compositions and diagnostic kits." This invention includes monoclonal antibodies selected from a specific group, including G-1-31-22, G-2-14-10, G-5-32-5, G-6-42-42, G-7-24-17, and G-7-27-18. These antibodies have broad applications in immunoprophylaxis and immunotherapy for infections caused by H5-serotype influenza viruses. The invention also encompasses hybridomas that produce these antibodies, along with compositions and diagnostic kits for detecting and typing H5-serotype influenza viruses in biological samples.

Career Highlights

Throughout her career, Anna has worked with prominent institutions such as Sieć Badawcza Lukasiewicz—Instytut Biotechnologii i Antybiotyków and Uniwersytet Gdański. Her experience in these organizations has allowed her to advance her research and contribute to significant scientific advancements.

Collaborations

Anna has collaborated with esteemed colleagues, including Violetta Sączyńska and Violetta Cecuda-Adamczewska. These partnerships have enriched her research and expanded the impact of her work in the field of biotechnology.

Conclusion

Anna Porębska is a pioneering inventor whose work on monoclonal antibodies has the potential to significantly improve the diagnosis and treatment of H5-serotype influenza viruses. Her contributions to biotechnology are invaluable and continue to influence the field positively.